GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 1418U
GlaxoSmithKline PLC
27 July 2015
 

GlaxoSmithKline plc

 

 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibilities or Connected Persons

 

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the Plan) notified the Company and the under-mentioned Directors, Persons Discharging Managerial Responsibilities ('PDMR') and Connected Persons on 24 July 2015 of the following increases in their notional interests in Ordinary Shares at a price of 1369.00 pence per Ordinary Share and American Depositary Shares ('ADSs') at a price of $41.80 per ADS following the notional re-investment of the dividend paid to shareholders on 9 July 2015.

 

Director/PDMR

Ordinary Shares

ADSs

Sir Andrew Witty

18997.185


Dr M M Slaoui


5596.705

Mr S Dingemans

8251.600


Mr R G Connor

3700.161


Mr N Hirons

592.901

205.521

Mr S A Hussain

7756.471


Mr W C Louv


1641.746

Mr D S Redfern

2813.799


Ms C Thomas

3910.257


Mr P C Thomson

1996.718


Mr D E Troy


3481.744

Dr P J T Vallance

8326.341


Ms E Walmsley

4816.457


Mrs V A Whyte

524.954


 

 

 

Connected Person

 

Ordinary Shares

 

       ADSs

Dr K Slaoui (Connected Person to Dr M M Slaoui)


      90.534

Mrs K Thomson (Connected Person to Mr P C Thomson)

          49.550


 

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).

 

 

V A Whyte

Company Secretary

27 July 2015

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSVDLBLEDFBBBQ